The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception最新文献

{"title":"Modern contraceptive use among women of reproductive age in Zimbabwe: analysis of 1999-2015 Zimbabwe Demographic Health Survey.","authors":"Joseph Lasong,&nbsp;Bassouma Bougangue,&nbsp;Yaa Nyarko Agyeman","doi":"10.1080/13625187.2022.2107198","DOIUrl":"https://doi.org/10.1080/13625187.2022.2107198","url":null,"abstract":"<p><strong>Introduction: </strong>Modern contraception use is the fundamental fulfilment of women's rights to choose when and how many children to have. The study explored predictors of modern contraceptive use among women in Zimbabwe.</p><p><strong>Method: </strong>Data from the 1999, 2005/2006, 2010/2011 and 2015 Zimbabwe Demographic and Health Survey (ZDHS) was used in a secondary analysis that involved 5474 women of reproductive age. The outcome measure was modern contraceptive use as reported by women. Multiple logistic regression was done to determine the predictors of modern contraceptive use.</p><p><strong>Results: </strong>The trend showed that since 1999 to 2015 there has been a steadily increase in modern contraceptive use from 54.9% to 72.9%. The use of contraceptives was lower among age 40 to 49 years (aOR = 0.49, <i>p</i> = 0.001)], other religion (aOR = 0.34, <i>p</i> = 0.005), induced abortion (aOR = 0.70; <i>p</i> ≤ 0.001), desire for having children within 2 years (aOR = 0.21; <i>p</i> ≤ 0.001) and polygamy (aOR = 0.43; <i>p</i> ≤ 0.001). The odds of contraceptives used was higher among richer wealth index (aOR = 1.45, <i>p</i> = 0.017), partners with higher education (aOR = 2.00, <i>p</i> = 0.029)], parity 1-2 (aOR = 15.53; <i>p</i> ≤ 0.001), 3-4 (aOR = 19.60; <i>p</i> ≤ 0.001), 5 or more (aOR = 17.50; <i>p</i> ≤ 0.001)] and media exposure (aOR = 1.79; <i>p</i> = 0.003).</p><p><strong>Conclusions: </strong>The study asserts that women's financial status, partners educational level, and media exposure might be important in promoting the use of modern contraceptives among women in a union in Zimbabwe and other low-income and middle-income countries.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"445-453"},"PeriodicalIF":1.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40704218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations.","authors":"Ioannis Tsakiridis,&nbsp;Sonia Giouleka,&nbsp;Georgia Koutsouki,&nbsp;Nikolaos Kostakis,&nbsp;Ioannis Kalogiannidis,&nbsp;Anargyros Kourtis,&nbsp;Apostolos Athanasiadis,&nbsp;Dimitrios G Goulis,&nbsp;Themistoklis Dagklis","doi":"10.1080/13625187.2022.2112169","DOIUrl":"https://doi.org/10.1080/13625187.2022.2112169","url":null,"abstract":"<p><strong>Purpose: </strong>To review and compare the most recently published recommendations on the investigation and management of abnormal uterine bleeding (AUB).</p><p><strong>Materials and methods: </strong>A descriptive review of recommendations from the American College of Obstetricians and Gynaecologists (ACOG), the National Institute for Health and Care Excellence (NICE), the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), the Society of Obstetricians and Gynaecologists of Canada (SOGC) and the International Federation of Gynaecology and Obstetrics (FIGO) on AUB in reproductive-aged women was carried out.</p><p><strong>Results: </strong>There is a consensus that detailed personal and family history along with physical examination are essential in the investigation of menstrual, intermenstrual or postcoital AUB. All the medical societies recommend transvaginal ultrasound as the first-line imaging modality to determine the AUB cause. Moreover, they agree (except for RANZCOG) that, in women with AUB, endometrial biopsy should only be performed if additional risk factors for endometrial cancer are present. Laboratory tests may be helpful in the AUB investigation; however, there are several discrepancies among the recommendations. Regarding AUB management, NICE, ACOG and SOGC agree that the administration of hormonal or non-hormonal medications should be the first-line treatment modality in bleeding disorders and absent or minor structural pelvic pathology. Surgical management should be preferred in cases of identified polyps, large fibroids or unsuccessful pharmacological treatment.</p><p><strong>Conclusions: </strong>Since AUB affects a significant proportion of reproductive-aged women, the main objective is to improve the quality of life of these patients without missing cases of malignancy.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"504-517"},"PeriodicalIF":1.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40345051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use.","authors":"Giovanni Grandi,&nbsp;Francesca Monari,&nbsp;Valentina Boggio Sola,&nbsp;Laura Cortesi,&nbsp;Angela Toss,&nbsp;Maria Chiara Del Savio,&nbsp;Chiara Melotti,&nbsp;Maria Grazia Centurioni,&nbsp;Claudio Gustavino,&nbsp;Liliana Varesco,&nbsp;Fabio Facchinetti,&nbsp;Fabio Barra","doi":"10.1080/13625187.2022.2107199","DOIUrl":"https://doi.org/10.1080/13625187.2022.2107199","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the actual perceptions about combined hormonal contraceptives (CHCs) use in BRCA mutation carriers in comparison to women from the general population.</p><p><strong>Methods: </strong>This was a cross-sectional, observational study involving two Italian referral centres for hereditary cancers. An identical questionnaire investigating how CHC use could affect the risk of developing some types of cancer, specific diseases, and symptoms was administered to 85 BRCA mutation carriers and 85 healthy women without this genetic mutation (control group). Women's perceptions were evaluated using specific questions and Likert scales (-5 to +5).</p><p><strong>Results: </strong>Perceptions about the effects of CHC use on developing specific diseases and symptoms did not differ between BRCA mutation carriers and controls. Conversely, the protective effects of CHC use on colorectal (<i>p</i> = .02), uterine body (<i>p</i> = .01) and ovarian (<i>p</i> = .01) cancers were unknown by BRCA mutation carriers. Moreover, BRCA mutation carriers recognised the association between CHC use and a higher risk of breast (<i>p</i> = .0008) and uterine cervix cancer (<i>p</i> = .007).</p><p><strong>Conclusions: </strong>Investing time and effort in transmitting the correct key messages about oncological risk related to CHC use could potentially increase their use in BRCA mutation carriers.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"439-444"},"PeriodicalIF":1.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40615033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Experiences of male partners of women with endometriosis-associated pelvic pain: a qualitative study.","authors":"Deborah Margatho,&nbsp;Maria Y Makuch,&nbsp;Luis Bahamondes","doi":"10.1080/13625187.2022.2097658","DOIUrl":"https://doi.org/10.1080/13625187.2022.2097658","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of the study was to assess the experiences of male partners of women with endometriosis-associated pain after medical treatment in their everyday lives.</p><p><strong>Methods: </strong>We conducted a phenomenological study based on semi-structured interviews with 11 male partners of women with endometriosis-associated pelvic pain at the Department of Obstetrics and Gynaecology, University of Campinas Medical School, Brazil. A thematic analysis of manifest content was performed, a coding frame was drafted, and the main analysis categories were elaborated.</p><p><strong>Results: </strong>The interviewed men had been in stable relationships for a median length of 14 years. They reported that they did not have information about endometriosis before their partners' diagnosis and that the endometriosis-associated pelvic pain suffered by their partners affected their personal everyday life, marital relationship, sexual relationship, and intimacy.</p><p><strong>Conclusion: </strong>Male partners of women with endometriosis-associated pain reported that the disease has both a profound impact on their lives and on their relationship. Our study contributed to an increased understanding of the life experience of men living with women with endometriosis-associated pelvic pain and may contribute to encourage healthcare professionals to incorporate strategies for guidance of the couple during treatment.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"454-460"},"PeriodicalIF":1.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40626547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The preferences of women in Australia for the features of long-acting reversible contraception: results of a discrete choice experiment.","authors":"Marion Haas,&nbsp;Jody Church,&nbsp;Deborah J Street,&nbsp;Deborah Bateson,&nbsp;Jane Fisher,&nbsp;Angela Taft,&nbsp;Kirsten I Black,&nbsp;Jayne Lucke,&nbsp;Safeera Y Hussainy,&nbsp;Kevin McGeechan,&nbsp;Wendy Norman,&nbsp;Danielle Mazza","doi":"10.1080/13625187.2022.2098947","DOIUrl":"https://doi.org/10.1080/13625187.2022.2098947","url":null,"abstract":"<p><strong>Purpose: </strong>Long-acting reversible contraceptives (LARC), such as intrauterine devices (IUD) and implants, are highly effective. However, the uptake of LARC in Australia has been slow and the oral contraceptive pill (OC) remains the best known and most widely used contraceptive. Our aim was to investigate women's preferences for the features of LARC.</p><p><strong>Methods: </strong>We used a discrete choice experiment (DCE) in which each respondent completed 12 choice tasks. We recruited a general population sample of 621 women in Australia aged 18-49 using an online survey panel. A mixed logit model was used to analyse DCE responses; a latent class model explored preference heterogeneity.</p><p><strong>Results: </strong>Overall, 391 (63%) of women were currently using contraception; 49.3% were using an OC. About 22% of women were using a LARC. Women prefer products that are more effective in preventing pregnancy, have low levels of adverse events (including negative effects on mood), and which their general practitioner (GP) recommends or says is suitable for them.</p><p><strong>Conclusions: </strong>Women have strong preferences for contraceptive products that are effective, safe, and recommended by their GP. The results indicate which characteristics of LARCs need to be front and centre in information material and in discussions between women and healthcare professionals.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"424-430"},"PeriodicalIF":1.7,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40651635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A novel estetrol-containing combined oral contraceptive: European expert panel review.","authors":"Kristina Gemzell-Danielsson,&nbsp;Angelo Cagnacci,&nbsp;Nathalie Chabbert-Buffet,&nbsp;Jonathan Douxfils,&nbsp;Jean-Michel Foidart,&nbsp;Ali Kubba,&nbsp;Luis Ignacio Lete Lasa,&nbsp;Diana Mansour,&nbsp;Joseph Neulen,&nbsp;Jaoquim Neves,&nbsp;Fátima Palma,&nbsp;Thomas Römer,&nbsp;Robert Spaczyński,&nbsp;Vera Tóth","doi":"10.1080/13625187.2022.2093850","DOIUrl":"https://doi.org/10.1080/13625187.2022.2093850","url":null,"abstract":"<p><strong>Purpose: </strong>Despite considerable advances in recently developed combined oral contraceptives (COCs), resulting in lower rates of adverse events while maintaining contraceptive efficacy, there is interest in further innovation.</p><p><strong>Materials and methods: </strong>Estetrol (E4), a native oestrogen, and progestin drospirenone (DRSP) were combined in a new COC. A European expert panel reviewed the pharmacology, efficacy, and safety and tolerability of this combination. Their findings are presented as a narrative review.</p><p><strong>Results: </strong>E4 15 mg/DRSP 3 mg in a 24/4 regimen provided effective contraception with good cycle control, characterised by a predictable regular bleeding pattern and minimal unscheduled bleeding, together with a good safety profile. The combination was associated with high user satisfaction, well-being, and minimal changes in body weight. The effects on endocrine and metabolic parameters were limited, and the combination was found to have a limited impact on liver function and lipid and carbohydrate metabolism. Moreover, its effect on several haemostatic parameters was lower than that of comparators containing ethinyl oestradiol (EE) 20 µg/DRSP 3 mg and EE 30 µg/levonorgestrel 150 µg.</p><p><strong>Conclusion: </strong>E4 15 mg/DRSP 3 mg provides safe and effective contraception, with high user satisfaction and predictable bleeding. Further research will evaluate the long-term safety of the COC.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"373-383"},"PeriodicalIF":1.7,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40635317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contraception among HIV-positive women in Latvia- knowledge, experience and factors influencing the choice.","authors":"Violeta Bule,&nbsp;Ieva Pitkevica,&nbsp;Gunta Lazdane","doi":"10.1080/13625187.2022.2088730","DOIUrl":"https://doi.org/10.1080/13625187.2022.2088730","url":null,"abstract":"<p><strong>Objectives: </strong>Latvia has one of the highest numbers of new HIV cases in the EU. The latest SRH national survey confirmed low effective contraceptive prevalence in the general population, no data were available about women living with HIV (WLHIV). The study aimed to assess knowledge on the use of different contraceptives, to identify factors in choosing contraception, to assess the availability of family planning health care services, and to investigate contraception habits.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among WLHIV aged 18-49 recruited with assistance of non-governmental organisations addressing HIV issues. Interviews in Latvian and Russian languages were based on pre-tested questionnaire. Data were processed and analysed using IBM SPSS 22.0.</p><p><strong>Results: </strong>102 WLHIV were interviewed and 99 of them met the inclusion criteria. Most women were aware of at least one effective contraceptive method yet around half of them had misconceptions about hormonal methods. Most of the women were able to evaluate the effectiveness of contraceptives. Sexually active women usually used male condoms (76.3%) although around 40% did not use them permanently especially if their partner was HIV-positive. Contraception usage after HIV infection decreased. Women mainly trusted medical professionals on information provided about contraceptives. Over 50% of women experienced situations they could not afford a visit to a gynaecologist or contraceptives.</p><p><strong>Conclusions: </strong>The survey showed a wide prevalence of misconceptions and prejudice about hormonal contraceptives. There is a need for health education including sexuality education and financial support to make effective contraception available and affordable for WLHIV.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"390-396"},"PeriodicalIF":1.7,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40395413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From request to dispensation: how adolescent and young adult females experience access to emergency contraception in pharmacies.","authors":"Yara Barrense-Dias,&nbsp;Sophie Stadelmann,&nbsp;Joan-Carles Suris,&nbsp;Christina Akre","doi":"10.1080/13625187.2022.2093849","DOIUrl":"https://doi.org/10.1080/13625187.2022.2093849","url":null,"abstract":"<p><strong>Purpose: </strong>Emergency contraception (EC) access was liberalised in 2002 in Switzerland by making it accessible in pharmacies without medical prescription. However, its dispensation still requires a confidential interview with a pharmacist. This qualitative study aims to explore experiences of adolescent and young adult (AYA) females who have gone to a pharmacy in order to obtain EC.</p><p><strong>Materials and methods: </strong>Thirty interviews were conducted from April to August 2019 with females aged between 15 and 25 years old at the interview. Inclusion criteria was to have requested at least one EC in a pharmacy between 2014 and 2019. A thematic content analysis was performed to extract themes brought up by the participants.</p><p><strong>Results: </strong>Some participants reported that the most difficult moment in the process was the request at the counter. The majority of participants were escorted in a private back room but opinions were divided regarding this isolation. Experiences were sometimes negative due to lack of information and knowledge regarding the dispensation process. The interview also has also a preventive aim, but the information given during it often focussed solely on the risk of vomiting. Several participants reported having perceived or received moral judgements from pharmacists.</p><p><strong>Conclusions: </strong>Pharmacists are key resources and EC dispensation an opportunity for sexual health. This exploratory study presents several elements requiring the adaptation of practices in order to prevent them from becoming barriers for AYA to access EC. Concerns are regularly expressed by young women about privacy, embarrassment and judgement in the pharmacy context regarding contraception.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"403-408"},"PeriodicalIF":1.7,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40615436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Use of contraception and attitudes towards contraceptive use in Swedish women: an internet-based nationwide survey.","authors":"Niklas Envall,&nbsp;Tove Wallström,&nbsp;Kristina Gemzell Danielsson,&nbsp;Helena Kopp Kallner","doi":"10.1080/13625187.2022.2094911","DOIUrl":"https://doi.org/10.1080/13625187.2022.2094911","url":null,"abstract":"<p><strong>Purpose: </strong>Explore contraceptive use, unmet need of and attitudes towards contraceptive use in Sweden. Secondly, to investigate knowledge of contraceptives, prevalence and outcomes of unintended pregnancies.</p><p><strong>Materials and methods: </strong>Internet based e-survey of Swedish women aged 16-49. The e-survey contained 49 questions with both spontaneous and multi-choice character on demographics, contraceptive use, knowledge of and attitudes towards contraception, importance of monthly bleeding, and experience of unintended pregnancy. The e-survey was closed when reaching the estimated sample size of 1000 respondents.</p><p><strong>Results: </strong>A total of 1016 women participated, whereof 62.4% used contraception, 31.8% did not and 5.8% had stopped in the last 12 months. Unmet need for contraception was estimated at 17.2%. At least one unintended pregnancy was experienced by 19.9%. All women rated effectiveness as the most important characteristic of a contraceptive method.</p><p><strong>Conclusions: </strong>Use of contraception in Swedish women remains low, 62.4%, and the unmet need for contraception has increased to 17.2%. Method effectiveness and health benefits of hormonal contraception should be emphasised during contraceptive counselling, and actions are needed to target groups with low use of effective contraception as well as to reach those who never seek contraception.KEY MESSAGEClose to one third of Swedish women do not use contraception and one fifth have experienced at least one unintended pregnancy. Unmet need for contraception is high despite easy access and subsidies for young women.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"409-417"},"PeriodicalIF":1.7,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40637316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge, professional attitudes, and training among health professionals regarding male contraceptive methods.","authors":"Jessica Tcherdukian,&nbsp;Roger Mieusset,&nbsp;Antoine Netter,&nbsp;Eric Lechevallier,&nbsp;Florence Bretelle,&nbsp;Jeanne Perrin","doi":"10.1080/13625187.2022.2093851","DOIUrl":"https://doi.org/10.1080/13625187.2022.2093851","url":null,"abstract":"<p><strong>Objectives: </strong>Health professionals are at the forefront of information and acceptability regarding contraceptive methods, however only one study evaluated their knowledge of male contraception (MC) including hormonal MC (HMC) and thermal MC (TMC). Our objective was to evaluate the knowledge, professional attitudes, and training of French practitioners regarding the management of couple contraception by male contraception (MC).</p><p><strong>Study design: </strong>We designed a descriptive, cross-sectional, multicentre study in 2,396 French practitioners belonging to national or regional institutions involved in contraception. We solicited practitioners by e-mail to complete an anonymous questionnaire; we analysed their knowledge, professional attitudes, and training regarding the management of couple contraception by MC.</p><p><strong>Results: </strong>The overall participation rate was 18% (427/2,396). Condoms, withdrawal, and vasectomy were known by 98%, 89%, and 76% of the population, respectively. Hormonal MC and Thermal (TMC) were known by 10% and 24% of the population, respectively. Fifty-five percent of the population never or infrequently offered MC during a couple's contraceptive request consultation. Only 14% of the population had ever participated in training on MC; 96% wanted to be better trained on MC, and 87% expressed a willingness to participate in training on the subject.</p><p><strong>Conclusions: </strong>Health professionals involved in contraception have unsatisfactory knowledge about MC methods based on spermatogenesis inhibition and are eager to have more information about them. To advance the acceptability and dissemination of MC methods, it seems imperative to enhance research in the field and to provide health professionals with an adapted training programme.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"397-402"},"PeriodicalIF":1.7,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40641082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}